MTOR and type 2 diabetes mellitus: mTORC1 hyperactivity and mTORC2 hypoactivity in the context of T2D have many diverse and complex outcomes on a number of metabolic pathways, but in this review, we will focus on the junctions between mTOR signaling and organelle performance.